JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267143

Human IFI16 knockout A549 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

IFI16 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 1 bp insertion in exon 2.

View Alternative Names

Gamma interferon inducible protein 16, Gamma-interferon-inducible protein Ifi16, IF16_HUMAN, IFNGIP1, Ifi-204, Interferon gamma induced protein IFI 16, Interferon gamma inducible protein 16, Interferon-inducible myeloid differentiation transcriptional activator, PYHIN2, interferon activated gene 204, p204

3 Images
Sanger Sequencing - Human IFI16 knockout A549 cell line (AB267143)
  • Sanger seq

Unknown

Sanger Sequencing - Human IFI16 knockout A549 cell line (AB267143)

Allele-2 : 1 bp insertion in exon 2.

Cell Culture - Human IFI16 knockout A549 cell line (AB267143)
  • Cell Culture

Unknown

Cell Culture - Human IFI16 knockout A549 cell line (AB267143)

Representative images of IFI16 knockout A549 cells, low and high confluency examples (top left and right respectively) and wild-type A549 cells, low and high confluency (bottom left and right respectively) showing typical adherent, epithelial-like morphology. Images were captured at 10X magnification using an EVOS M5000 microscope.

Sanger Sequencing - Human IFI16 knockout A549 cell line (AB267143)
  • Sanger seq

Unknown

Sanger Sequencing - Human IFI16 knockout A549 cell line (AB267143)

Allele-1 : 1 bp deletion in exon2

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 1 bp insertion in exon 2

Antibiotic resistance

Puromycin 1µg/mL

Disease

Carcinoma

Product details

Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267143-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267143 Human IFI16 knockout A549 cell line", "number":"AB267143-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
IFI16
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium

F-12K + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The IFI16 protein also known as Interferon γ Inducible Protein 16 is a DNA sensor belonging to the PYHIN family with a molecular mass of approximately 85 kDa. Widely expressed in the nucleus and cytoplasm its primary role involves detecting foreign DNA within cells. It possesses a pyrin domain two HIN-200 domains and also plays a role in regulating gene expression particularly in response to pathogen infection. This versatile protein can act in multiple cellular environments and its location within the cell can dictate its function.
Biological function summary

IFI16 protein participates in the innate immune response by recognizing viral and bacterial double-stranded DNA. It forms part of a signaling complex that activates pathogen recognition receptors and induces the production of type I interferons. IFI16 can interact with various DNA sensors and is known for its ability to bind DNA directly providing a defense mechanism against infection. The protein also plays a role in the regulation of transcription which contributes to cell growth and differentiation.

Pathways

IFI16 protein has significant roles in the cGAS-STING and BRCA1 pathways. It interacts with cGAS to regulate the production of cyclic GMP-AMP activating STING and promoting antiviral responses. Additionally IFI16 aligns with BRCA1 dysfunction impacting DNA repair processes. This interaction underlines its involvement in maintaining genomic integrity and modulating the immune responses along with cGAS STING and BRCA1 proteins which are critical in these pathways.

IFI16 protein plays a role in autoimmune diseases and various cancers. In Systemic Lupus Erythematosus (SLE) it can induce inflammation by recognizing self-DNA leading to chronic immune activation. In certain cancers its expression levels correlate with malignancy where it influences tumor progression and response to therapy. In these contexts IFI16 interacts closely with cGAS and BRCA1 proteins highlighting its relevance to disease mechanisms and offering potential therapeutic targets.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com